PVIVAX

Knowledge sharing for relapsing malaria

PVIVAX Knowledge sharing for relapsing malaria

Search

  • P. vivax malaria
    • Malaria and P. vivax malaria
    • Symptoms & severity
    • Illness and mortality
    • Populations at risk
      • Pregnant women and children
      • Migratory populations
    • Role in malaria elimination
    • Lifecycle
    • Relapses
    • Vectors
  • Diagnosis & treatment
    • Diagnostic methods
      • Microscopy
      • Rapid diagnostic tests
      • Molecular methods & serology
    • Diagnosing severe vivax malaria
    • Treatment
      • Radical cure
      • Blood stage treatment
      • Liver stage treatment
    • G6PD Deficiency
      • G6PD Global Prevalence
      • G6PD diagnostics
      • Types of G6PD clinical diagnostic tests
  • Regions & countries
    • Africa
    • Eastern Mediterranean
    • South East Asia
    • The Americas
    • Western Pacific
  • In the field
    • Projects
      • The Partnership for Vivax Elimination (PAVE)
    • Stories and Videos
  • Tools
    • Study database
  • Resources
  • News & events
    • Past events
  • About us
HomeNews & events

News

1

Photo: Fundação de Medicina Tropical

Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of P. vivax malaria

31 Oct 2019
Photo: Cristina Donini/MMV

MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria

22 Oct 2019
Photo: PATH

Expert Review Panel for Diagnostics approval expands access to a G6PD deficiency test that supports P. vivax malaria treatment and elimination initiatives

03 Oct 2019
Photo: Cristina Donini/MMV

Tafequine featured as a key health innovation

31 Aug 2019
Photo: Marco Corsi/Sigma Tau

New maps could show how to beat malaria

24 Jun 2019

PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria

23 Apr 2019

New opportunities to prevent P. vivax malaria relapse

25 Feb 2019

A high risk of P. vivax after P. falciparum infection

13 Feb 2019
Photo: Damien Schumann/MMV

Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria

16 Jan 2019
Photo: Fundação de Medicina Tropical

Single-dose tafenoquine for radical cure of P. vivax malaria submitted for regulatory approval in Brazil

21 Sep 2018
Photo: BMC St Jude

Kozenis (tafenoquine) approved by the Australian Therapeutic Goods Administration for the radical cure of P. vivax malaria

21 Sep 2018
Photo: Maud Lugand/MMV

US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria

20 Jul 2018

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »
1

Events

Disclaimer

Disclaimer: MMV accepts no liability for the information presented here or for the consequences of any actions taken on the basis of this information. 

Subscribe to our newsletter

Get in touch

Contact us.

Submit information

Subscribe

Follow us

  • Twitter
  • LinkedIn
  • Facebook
  • Disclaimer
  • Privacy policy
A Remora website by Manta Ray Media